SLC33A1 antibody (AA 110-190)
Quick Overview for SLC33A1 antibody (AA 110-190) (ABIN7227166)
Target
See all SLC33A1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 110-190
-
Purpose
- ACATN Polyclonal Antibody
-
Specificity
- The antibody detects endogenous levels of ACATN protein
-
Purification
- The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen
-
Immunogen
- Synthesized peptide derived from part region of human ACATN protein at AA range: 110-190
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000-1:20000).
-
Comment
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium Azide as preservative and 50 % Glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- SLC33A1 (Solute Carrier Family 33 Member 1 (SLC33A1))
-
Alternative Name
- ACATN
-
Background
- Rabbit Anti-ACATN Polyclonal Antibody,Acetyl-coenzyme A transporter 1, AT-1, Acetyl-CoA transporter 1, Solute carrier family 33 member 1,SLC33A1 (Solute Carrier Family 33 Member 1) is a Protein Coding gene. Diseases associated with SLC33A1 include Congenital Cataracts, Hearing Loss, And Neurodegeneration and Spastic Paraplegia 42, Autosomal Dominant. Among its related pathways are Metabolism and Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds.,ACATN
-
Gene ID
- 9197
-
UniProt
- O00400
Target
-